Director of Finance-BioPharma

Interim Director of Finance - Manufacturing

Director of Finance-BioPharma

Increased
reporting visibility
We assigned the interim a project to prepare a P&L statement only for the new products tech transfer products. He completed the P&L providing critical information to senior management necessary to plan and execute a cost restructuring. Also, we had a positive realignment among the functional departments as a result of the new information the interim provided.
Company Profile
Publicly traded company
Biopharma Manufacturing
> $1 billion in revenues
Position/Timeframe
Interim Director of Finance
2 months
Situation
Company had agressive goals for increasing revenue
Ambitious plan for developing numerous new products
Development costs skyrocketed and affected EBITDA but no visibility to full impact
Implementation
Created a complex matrix and designed a control program to forecast & track expenses
Created detailed forecast P&L and YTD actual per project
Redesigned reporting to faciliate population of forecast and actual figures
Trained staff for on-going accuracy of reporting

Results

  • Top management of corporation now have full visibility
  • Flexibility reporting model to help assure EBITDA goals will be attained